Switchability of drug products: scientists vs. lawmakers
- At: 2004 FIP Congress in New Orleans (USA)
- Type: Presentation
- By: DRESSMAN, Jennifer (Institute of Pharmaceutical Technology, J.W. Goethe University, Frankfurt Am Main, Germany)
For many years now, regulations have been in place setting out the requirements for generic substitution of drug products. Important requirements include pharmaceutical equivalence, bioequivalence and therapeutic equivalence of the generic product with the reference product. While various authorities differ slightly in their definitions of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.